A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease

Clinical trial NCT02473445 · TERMINATED

Trial details

NCT number: NCT02473445
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Mitochondrial Diseases

Start date: 2015-05-19
Primary completion: 2017-03-06
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.